中国药事
中國藥事
중국약사
CHINESE PHARMACEUTICAL AFFAIRS
2014年
10期
1093-1098
,共6页
周玲%王丹%吕强%何雨桐%沈传勇%刘爽%樊晓东%魏澜
週玲%王丹%呂彊%何雨桐%瀋傳勇%劉爽%樊曉東%魏瀾
주령%왕단%려강%하우동%침전용%류상%번효동%위란
中药材%GAP%合作种植%价格调控%持续改进
中藥材%GAP%閤作種植%價格調控%持續改進
중약재%GAP%합작충식%개격조공%지속개진
Chinese herbal medicine%GAP%cooperative plantation%price regulation%sustainable improvement
目的:了解中药材生产与中药制剂生产的情况,促使《中药材生产质量管理规范》(GAP)和《药品生产质量管理规范》(GMP)相互结合,进一步推动中药材 GAP 实施。方法采取现场走访、与企业座谈及发放调查问卷相结合的方式进行调研,根据调研情况和对问卷的统计分析得出调研结果。结果与结论中药材 GAP 自发布以来已经实施十多年,但在 GAP 认证体系建设、基地建设与政策扶持、推进中药材GAP 进程方面仍有待深入总结研究。调研显示,种植和使用 GAP 药材成本提高导致价格竞争力减弱,挫伤了企业实施中药材 GAP 的积极性;公司与农户合作种植的模式存在农户积极性降低、对农户制约不严、产品溯源性差等弊端;缺乏有效的中药材价格调控机制;GAP 药材的种植管理缺乏一致性。建议参照新修订药品 GMP 的评定方式,对中药材 GAP 种植企业实施可持续性地改进。
目的:瞭解中藥材生產與中藥製劑生產的情況,促使《中藥材生產質量管理規範》(GAP)和《藥品生產質量管理規範》(GMP)相互結閤,進一步推動中藥材 GAP 實施。方法採取現場走訪、與企業座談及髮放調查問捲相結閤的方式進行調研,根據調研情況和對問捲的統計分析得齣調研結果。結果與結論中藥材 GAP 自髮佈以來已經實施十多年,但在 GAP 認證體繫建設、基地建設與政策扶持、推進中藥材GAP 進程方麵仍有待深入總結研究。調研顯示,種植和使用 GAP 藥材成本提高導緻價格競爭力減弱,挫傷瞭企業實施中藥材 GAP 的積極性;公司與農戶閤作種植的模式存在農戶積極性降低、對農戶製約不嚴、產品溯源性差等弊耑;缺乏有效的中藥材價格調控機製;GAP 藥材的種植管理缺乏一緻性。建議參照新脩訂藥品 GMP 的評定方式,對中藥材 GAP 種植企業實施可持續性地改進。
목적:료해중약재생산여중약제제생산적정황,촉사《중약재생산질량관리규범》(GAP)화《약품생산질량관리규범》(GMP)상호결합,진일보추동중약재 GAP 실시。방법채취현장주방、여기업좌담급발방조사문권상결합적방식진행조연,근거조연정황화대문권적통계분석득출조연결과。결과여결론중약재 GAP 자발포이래이경실시십다년,단재 GAP 인증체계건설、기지건설여정책부지、추진중약재GAP 진정방면잉유대심입총결연구。조연현시,충식화사용 GAP 약재성본제고도치개격경쟁력감약,좌상료기업실시중약재 GAP 적적겁성;공사여농호합작충식적모식존재농호적겁성강저、대농호제약불엄、산품소원성차등폐단;결핍유효적중약재개격조공궤제;GAP 약재적충식관리결핍일치성。건의삼조신수정약품 GMP 적평정방식,대중약재 GAP 충식기업실시가지속성지개진。
Objective To understand the situation of traditional Chinese material medical production and traditional Chinese preparation production,facilitate the integration of GAP for the traditional Chinese medicinal materials and GMP for drugs and further promote the implementation of GAP for traditional Chinese herbal medicine.Methods Research was carried out by means of on-site visits,discussions with manufacturers as well as statistical analyses based on findings from questionnaires. Results and Conclusion Though GAP has been implemented more than a decade since its release,it still remains to be further explored in the aspects of GAP certification system construction,base construction and policy support and promotion of the process of GAP for traditional Chinese medicinal materials.Researches demonstrate that the rise in the cost of planting and using the GAP medicinal materials leads to weak price competitiveness and dampens the enthusiasm of enterprises to implement GAP for traditional Chinese medicinal materials;drawbacks still exist in the cooperative planting pattern between companies and farmers,such as undermined motivation of the farmers,loose restriction on the farmers and poor product traceability;lack of an effective regulatory mechanism for traditional Chinese herbal medicine prices and the consistency of plantation management of GAP medicinal materials.It is recommended to carry out sustainable improvement for traditional Chinese herbal medicine GAP planting enterprises based on the evaluation methods of the new GMP.